292 p53 Transcriptionally activates IRF9 to enhance antiviral immunity

MLA

César Muñoz-Fontela, et al. “292 P53 Transcriptionally Activates IRF9 to Enhance Antiviral Immunity.” Cytokine, vol. 43, Sept. 2008, pp. 312–13. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........1c18b7aa61fe8e3a4716ede1dbf76153&authtype=sso&custid=ns315887.

APA

César Muñoz-Fontela, Adolfo García-Sastre, Salvador Macip, Lauren Brown, Sam W. Lee, Stuart A. Aaronson, Joseph Ashour, Rana Elkholi, & Luis Martinez-Sobrido. (2008). 292 p53 Transcriptionally activates IRF9 to enhance antiviral immunity. Cytokine, 43, 312–313.

Chicago

César Muñoz-Fontela, Adolfo García-Sastre, Salvador Macip, Lauren Brown, Sam W. Lee, Stuart A. Aaronson, Joseph Ashour, Rana Elkholi, and Luis Martinez-Sobrido. 2008. “292 P53 Transcriptionally Activates IRF9 to Enhance Antiviral Immunity.” Cytokine 43 (September): 312–13. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........1c18b7aa61fe8e3a4716ede1dbf76153&authtype=sso&custid=ns315887.